These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 5161569)

  • 1. Stability of erythrocytic adenosine triphosphate (ATP) and its relation to the activity of pyruvate kinase (PK) in Hb. E-thalassaemia disease.
    Swarup-Mitra S; Ghosh SK; Chatterjea JB
    Indian J Med Res; 1971 Sep; 59(9):1430-4. PubMed ID: 5161569
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity of pyruvate kinase (PK) and stability of ATP in heterozygous and homozygous states for Hb-E.
    Mitra SS; Ghosh SK; Chatterjea JB
    Bull Calcutta Sch Trop Med; 1968 Oct; 16(4):103-4. PubMed ID: 5731041
    [No Abstract]   [Full Text] [Related]  

  • 3. Erythrocytic adenosine triphosphate (ATP) level and its stability in Hb. E-thalassaemia.
    Swarup S; Ghosh SK; Dutta MC; Chatterjea JB
    Bull Calcutta Sch Trop Med; 1966 Jan; 14(1):3. PubMed ID: 5961042
    [No Abstract]   [Full Text] [Related]  

  • 4. Elevated ATP level, high activity of PK and hereditary spherocytosis--triple erythrocytic anomaly.
    Swarup-Mitra S; Ghosh SK
    Indian J Med Res; 1978 Feb; 67():263-8. PubMed ID: 680884
    [No Abstract]   [Full Text] [Related]  

  • 5. Enzymic stability of red cells in iron deficiency anaemia. I. Stability of adenosine triphosphate and activity of pyruvate kinase.
    Swarup-Mitra S; Ghosh SK; Chatterjea JB
    Bull Calcutta Sch Trop Med; 1971 Oct; 19(4):79-80. PubMed ID: 5161532
    [No Abstract]   [Full Text] [Related]  

  • 6. A biochemical study of erythrocytes in Swedish families with beta-thalassaemia minor.
    Hjelm M; Samuelson G
    Scand J Haematol; 1974; 13(2):101-9. PubMed ID: 4278868
    [No Abstract]   [Full Text] [Related]  

  • 7. The ATP level and pyruvate kinase activity in dog red cells.
    Jabłońska-Skwiecińska E; Sawicka B; Kłopocka J
    Acta Physiol Pol; 1980; 31(1):31-4. PubMed ID: 7376896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Congenital nonspherocytic hemolytic anemia with deficiency of erythrocytic pyruvate kinase].
    Busch D
    Folia Haematol (Frankf); 1964 Oct; 9(2):89-118. PubMed ID: 5888692
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on pyruvate kinase (PK) deficiency. I. Clinical, hematological and erythrocyte enzyme studies.
    Miwa S; Nishina T
    Nihon Ketsueki Gakkai Zasshi; 1974 Feb; 37(1):1-16. PubMed ID: 4858633
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of in vivo hyperoxia on erythrocytes. 8. Effect on adenosine triphosphate (ATP) and related glycolytic enzymes.
    Smith D; Timms R; Mengel CE; Jefferson DH
    Johns Hopkins Med J; 1968 Mar; 122(3):168-71. PubMed ID: 4230737
    [No Abstract]   [Full Text] [Related]  

  • 11. [Glucose-6-phosphate dehydrogenase and pyruvate kinase activity and the content of adenosine triphosphate in the erythrocytes of leukemic patients].
    Gekova K; Arsov Ts; Georgieva B
    Vutr Boles; 1979; 18(4):74-8. PubMed ID: 291225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme studies for carbohydrate metabolism in thalassaemia and some other clinical conditions. II. Determination of RBC-pyruvate kinase.
    Nath RL; Das S
    Enzymologia; 1966 Nov; 31(5):303-8. PubMed ID: 6005336
    [No Abstract]   [Full Text] [Related]  

  • 13. [Double heterozygous predisposition for Hb P ( 2 2 117 His--Arg ) and the classic -thalassemia in an Aargau-family].
    Rosenmund A; Winterhalter KH; Haber J; Marti HR
    Schweiz Med Wochenschr; 1972 Nov; 102(44):1624-6. PubMed ID: 4645055
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of cytostatic therapy on pyruvate kinase activity in the erythrocytes of patients with acute myelocytic leukemia].
    Labar B; Jusufhodzić L
    Lijec Vjesn; 1985 Feb; 107(2):61-3. PubMed ID: 3856722
    [No Abstract]   [Full Text] [Related]  

  • 15. Preliminary observations on the activity of pyruvate kinase in Hb. E thalassemia disease.
    Mitra SS; Ghosh SK; Chatterjea JB
    Bull Calcutta Sch Trop Med; 1967 Jul; 15(3):94-5. PubMed ID: 5616302
    [No Abstract]   [Full Text] [Related]  

  • 16. Pyruvate kinase and the "high ATP syndrome".
    Staal GE; Jansen G; Roos D
    J Clin Invest; 1984 Jul; 74(1):231-5. PubMed ID: 6736249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G-->T transition at cDNA nt 110 (K37Q) in the PKLR (pyruvate kinase) gene is the molecular basis of a case of hereditary increase of red blood cell ATP.
    Beutler E; Westwood B; van Zwieten R; Roos D
    Hum Mutat; 1997; 9(3):282-5. PubMed ID: 9090535
    [No Abstract]   [Full Text] [Related]  

  • 18. Decreased erythrocyte phosphoribosylpyrophosphate synthetase activity and impaired formation in thalassemia minor: a mechanism for decreased adenine nucleotide content.
    Zerez CR; Lachant NA; Tanaka KR
    J Lab Clin Med; 1989 Jul; 114(1):43-50. PubMed ID: 2544652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocyte pyruvate kinase deficiency. The influence of physiologically important metabolites on the function of normal and defective enzymes.
    Lakomek M; Winkler H; Pekrun A; Krüger N; Sander M; Huppke P; Schröter W
    Enzyme Protein; 1994-1995; 48(3):149-63. PubMed ID: 8589802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of erythrocytic pyruvate kinase (PK) in leukaemia.
    Rakshit MM; Basu AK
    Bull Calcutta Sch Trop Med; 1973 Apr; 21(2):24-6. PubMed ID: 4807410
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.